Previous close | 121.30 |
Open | 121.45 |
Bid | 0.00 x 1100 |
Ask | 0.00 x 900 |
Day's range | 118.62 - 121.45 |
52-week range | 102.00 - 149.25 |
Volume | |
Avg. volume | 1,435,709 |
Market cap | 24.518B |
Beta (5Y monthly) | 1.02 |
PE ratio (TTM) | 24.45 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.96 (0.80%) |
Ex-dividend date | 27 Mar 2024 |
1y target est | N/A |
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced partnerships with three top pickleball organizations in the United States, becoming the first and only medical device partner for the sport of pickleball. As partners of Zimmer Biomet, the Association of Pickleball Players (APP), Professional Pickleball Association (PPA Tour), and USA Pickleball, the National Governing Body for pickleball, have aligned with the company to alleviate pain and impr
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its first quarter earnings conference call will be webcast on Thursday, May 2, 2024 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET.
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the ROSA® Shoulder System for robotic-assisted shoulder replacement surgery. ROSA Shoulder is the world's first robotic surgery system for shoulder replacement, and the fourth application for the Company's comprehensive ROSA® Robotics portfolio, which includes the ROSA® Knee System for total knee arthroplasty and ROSA® Hip System for to